Stock Ratings / Consumer Discretionary / TBI / forecast

III (70) HCKT (66) RCMT (76) HQI (63) ⌘ Pro Terminal →

TrueBlue Inc. (TBI) 12-Month Stock Forecast & Price Target Cone

$9.76 +0.41% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $9.75

TrueBlue Inc. (TBI) carries a Roarable Rating of D- (Sell) with 38/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (38/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $297.1M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $9.75 (-0.12%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (38/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.8% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for TBI)Realized 20D OHLCV Swing Band: ±9.1%

Deterministic 5-Pillar Attribution (38/100 Composite)

🔍 WHY TBI SCORES 38/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+12/20 pts (32% of score)

FRED Regime × Technicals: 84% of 52W Range • RSI-14 at 60.9 (BULLISH MOMENTUM)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (26% of score)

Altman Z-Score 3.73 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 3/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$8.87-6.7% Next Q

Q2 (-2Q)

Grade E$8.28+12.8% Next Q

Q3 (-1Q)

Grade E$9.34+4.5% Next Q

Current

Grade D-$9.76-7.8% Hist 90D α

Trajectory: E (30) → D- (38)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a TBI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While TBI currently carries a cautious 38/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($9.42) and Max Pain ($10.25) forces dealer call-delta covering toward $11.58.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $TBI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “TBI Beats Next Quarter EPS Consensus (Dec 27, 2026) & Holds Above 200D SMA”

YES 38%NO 62%Trade / Inspect Odds →

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your TBI Position Size: $10,000

Shares at $9.76: 1024.6 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $6.93

$7,100

$-2,900 (-29.0%)

12M Consensus BaseTarget $8.88

$9,098

$-902 (-9.0%)

12M Bull Case BreakoutTarget $11.58

$11,865

+$1,865 (+18.6%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (35 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 9

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$9	74%	A
Goldman SachsSector Coverage Lead	UNDERPERFORM	$11	69%	B
JP MorganUS Large-Cap Research	SELL	$8	58%	C

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring TBI)

✓Walkthrough of TBI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

TBI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +77.78%⚡ TESTING RESISTANCE

2026-10-30O $9.73H $9.82L $9.60C $9.76VOL 167.3K

RES: $9.88SUP: $8.32SMA50: $9.42SMA200: $6.79

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

TBI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 TBI Butterfly Map → + Track TBI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on TBI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for TBI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for TBI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (TBI)

Consumer Discretionary Rank #853 of 1011 ⚔️ III vs TBI Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (TBI vs. III, HCKT, RCMT, HQI)

Industry: Professional Services (48 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, TrueBlue Inc. (TBI) ranks #853 by composite RQD confidence (38/100, grade D-) and #647 by equity capitalization ($297.1M). Within this direct 5-issuer industry benchmark cohort, RCMT leads on earnings valuation at 15.6x trailing P/E, while RCMT leads on capital efficiency and profitability with 46.0% ROIC and 27.5% gross margin. RCMT currently holds the highest overall quantitative score in the immediate peer group at 76/100 (B+) compared with TBI at 38/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
TBI ACTIVE TrueBlue Inc.	D-	38/100	—	22.8%	-11.7%	+0.41%	$297.1M	Benchmark Subject
III Information Services Group Inc.	B-	70/100	31.5x	43.1%	11.2%	+0.33%	$294.4M	/iii-vs-tbi →
HCKT Hackett Group Inc .	C+	66/100	24.3x	38.3%	14.8%	+0.72%	$314.0M	/hckt-vs-tbi →
RCMT RCM Technologies Inc.	B+	76/100	15.6x	27.5%	46.0%	-0.69%	$255.3M	/rcmt-vs-tbi →
HQI HireQuest Inc.	C	63/100	35.8x	—	7.3%	-3.26%	$226.6M	/hqi-vs-tbi →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-28 • CIK 0000768899

In its most recent audited fiscal period (FY2025, filed 2025-12-28), TrueBlue Inc. (TBI) reported GAAP revenue of $1.62B (+3.1% vs. FY2024 revenue of $1.57B ) , GAAP net income of -$48.0M, operating cash flow of -$58.0M, and free cash flow of -$73.7M (-78.9% YoY). On the balance sheet, TBI closed FY2025 with $638.7M in total assets against $65.8M in total debt (Altman Z-Score: 3.73, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-28	$1.62B	-$48.0M	-$58.0M	-$73.7M	$638.7M	$65.8M
FY2024 (FY)	2024-12-29	$1.57B	-$125.7M	-$17.1M	-$41.2M	$675.4M	$7.6M
FY2023 (FY)	2023-12-31	$0	-$14.2M	$34.8M	$34.8M	—	—

3. TBI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is TBI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, TrueBlue Inc. (NYSE: TBI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 38/100 at a spot price of $9.76 (+0.41% 1D, market cap $297.1M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 3/20. Across 1011 tracked Consumer Discretionary issuers, TBI ranks #853 in composite RQD confidence.

How does TBI compare to III and HCKT in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Professional Services), TBI carries a Roarable D- (38/100 RQD), trailing P/E of N/A, gross margin of 22.8%, and ROIC of -11.7%. By comparison, III (Information Services Group Inc.) holds a B- grade (70/100 RQD, P/E 31.5x, ROIC 11.2%, cap $294.4M) and HCKT (Hackett Group Inc .) posts a C+ grade (66/100 RQD, P/E 24.3x, ROIC 14.8%, cap $314.0M). Among the 5-stock peer group, RCMT leads on earnings multiple (15.6x) while RCMT leads on capital efficiency (46.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for TBI?

Per TBI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-28, CIK 0000768899), TrueBlue Inc. generated $1.62B in revenue (+3.1% YoY), -$48.0M in net income, and -$73.7M in free cash flow against $638.7M in total assets and $65.8M in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is TBI trading relative to its 50-day, 200-day, and 52-week technical levels?

TBI last traded at $9.76 (+0.41% on volume of 172,719 shares), positioning the stock +3.61% above its 50-day simple moving average ($9.42) and +43.74% above its 200-day simple moving average ($6.79). Across its 52-week range of $3.18 to $11.03, TBI sits at the 83.8% percentile with a 14-day RSI of 60.9 (BULLISH MOMENTUM) and an implied next-earnings move of ±9.1% ($8.87 to $10.65).

TBI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is TBI's 12-month stock price target?

TrueBlue Inc. (TBI) carries a 12-month consensus base price target of $8.88 (-9% from $9.76), with a bull-case target of $11.58 and a bear-case floor of $6.93.

Is TBI stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates TBI D- (Sell — SELL) with an RQD Confidence score of 38/100.

Direct Sub-Reports: TBI RQD Cockpit TBI 12M Forecast TBI Earnings & Move TBI Dividends & DRIP TBI Insiders & 13F TBI Whale Options TBI Profit Sankey TBI News & Why